Journal of Biosciences

, Volume 37, Issue 1, pp 33–39 | Cite as

TP53 codon 72 polymorphism in pigmentary phenotypes



The p53 protein exerts different cellular functions, and recent findings have demonstrated its influence on the cascade of skin pigmentation during UV exposure. Among TP53 gene polymorphisms, the most studied is the G to C transversion in exon 4 at codon 72, which results in three distinct genotypes, Arg/Arg, Pro/Pro and Arg/Pro, each one encoding different p53 isoforms. Therefore, this study aimed to determine the relationship between TP53 codon 72 polymorphism and skin protection against sunburn. Genomic DNA was extracted from peripheral blood samples and genotyping was performed by PCR and confirmed by restriction enzyme digestion. The genotype frequency was 50% for Arg/Arg and 14.6% for Pro/Pro genotype. The frequency of heterozygous subjects was 35.4%. In our population, p53 genotypes were in Hardy–Weinberg (HW) equilibrium (χ2 HM < 3.84), showing a predominance of arginine allele (total Arg allele frequency of 68%). No significant association between p53 genotype and skin colour, hair or eye colour and susceptibility to sun exposure was found. However, further analysis demonstrated a significant association between the genotype Pro/Pro and blue/green eyes among participants who presented redness (P = 0.016). Our findings indicate susceptibility to sun exposure when this phenotype (eye colour) occurs simultaneously with Pro/Pro genotype.


Polymorphism p53 pigmentation traits sunlight susceptibility 



We thank the Instituto de Hematologia Goiano (INGOH) staff and participants for their attention and collaboration. This work was supported by the Brazilian agencies CNPq and FUNAPE. KAC was supported by CAPES.


  1. Benjamin CL, Ullrich SE, Kripke ML and Ananthaswamy H 2008 p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer. Photochem. Protobiol. 84 55–62Google Scholar
  2. Cui R, Widlund HR, Feige E, Lin J Y, Wilensky DL, Igras VE, D’Orazio J, Fung CY, et al. 2007 Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128 853–864PubMedCrossRefGoogle Scholar
  3. Dumont P, Leu JI, Della Pietra AC, George DL and Myrphy M 2003 The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 33 357–365PubMedCrossRefGoogle Scholar
  4. Ferreira LB, Mendes-Junior CT, Wiezel CEV, Luizon MR amd Simões AL 2006 Y-STR diversity and ethnic admixture in White and Mulato Brazilian population samples. Gen. Mol. Biol 29 605–607CrossRefGoogle Scholar
  5. Fitzpatrick TB 1988 The validity and practically of sun-reactive skin types I through VI. Arch. Dermatol. 124 869–871PubMedCrossRefGoogle Scholar
  6. Franchi A, Massi D, Gallo O, Santucci M and Porfirio B 2006 Radiation-induced cutaneous carcinoma of the head and neck: is there an early role for p53 mutations? Clin. Exp. Dermatol. 31 793–798PubMedCrossRefGoogle Scholar
  7. Han J, Kraft P, Nan H, Guo Q, Chen C, Qureshi A, Hankinson SE, Hu FB, et al. 2008 A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet. 4 e1000074PubMedCrossRefGoogle Scholar
  8. Hsieh YY and Lin CS 2006 p53 Codon 11, 72, and 248 gene polymorphisms in endometriosis. Int. J. Biol. Sci. 2 188–193PubMedCrossRefGoogle Scholar
  9. IARC (International Agency for Research on Cancer) 2011 Polymorphisms in the TP53 gene
  10. McGregor JM, Harwood CA, Brooks L, Fisher SA, Kelly DA, O’nions J, Young AR, Surentheran T, et al. 2002 Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J. Invest. Dermatol. 119 84–90PubMedCrossRefGoogle Scholar
  11. Nan H, Qureshi AA, Hunter DJ and Han J 2008 Interaction between p53 codon 72 polymorfism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk. Br. J. Dermatol. 159 314–321PubMedCrossRefGoogle Scholar
  12. Nelson HH, Wilkjomen M, Marsit CJ and Keisey KT 2005 TP53 mutation, allelism and survival in non-small cell lung cancer. Carcinogenesis 26 1770–1773PubMedCrossRefGoogle Scholar
  13. Ørsted DD, Bojesen SE, Tybjaerg-Hansen A and Nordestgaard BG 2007 Tumor supressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population. J. Exp. Med. 204 1295–1301PubMedCrossRefGoogle Scholar
  14. Pezeshki A, Sari-Aslanl F, Ghaderi A and Doroudchi M 2006 p53 codon 72 polimorphism in basal cell carcinoma of the skin. Pathol. Oncol. Res. 12 29–33PubMedCrossRefGoogle Scholar
  15. Pim D and Banks L 2004 p53 polymorphic variants at codon 72 exert different effects in cell cycle progression. Int. J. Cancer 108 196–199PubMedCrossRefGoogle Scholar
  16. Rees JL 2004 The genetics of sun sensitivity in humans. Am. J. Hum. Genet. 75 739–751PubMedCrossRefGoogle Scholar
  17. Shen H, Liu Z, Strom SS, Spitz MR, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, et al. 2003 p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. J. Invest. Dermatol. 121 1510–1514PubMedCrossRefGoogle Scholar
  18. Shu K, Li B and Wu LX 2007 The p53 network: p53 and its downstream genes. Colloids Surf. B Biointerfaces 55 10–18PubMedCrossRefGoogle Scholar
  19. Själander A, Birgander R, Saha N, Beckman L and Beckman G 1996 p53 polymorphisms and haplotypes show distinct differences between major ethnic groups. Human Hered. 46 41–48Google Scholar
  20. Stefanaki I, Stratigos AJ, Dimisianos G, Nikolaou V, Papadopoulos O, Polydorou D, Gogas H, Tsoutsos D, et al. 2007 p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants. Br. J. Dermatol. 156 357–362PubMedCrossRefGoogle Scholar
  21. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Judith Breuer, Leigh IM, Matalashewski G and Banks L 1998 Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer. Nature 393 229–234PubMedCrossRefGoogle Scholar
  22. Sucheston L, Witonsky DB, Hastings D, Yildiz O, Clark VJ, Di Rienzo A and Onel K 2011 Natural selection and functional genetic variation in the p53 pathway. Hum. Mol. Genet. 15 1502–1508Google Scholar
  23. Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Farrell PJ, Smith P, Lu X and Crook T 2004 Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 23 3328–3337PubMedCrossRefGoogle Scholar
  24. Thomas M, Kalita A, Labrecque S, Pim D, Banks L and Matlashewki G 1999 Two polymorphic forms of wild type p53 differ biochemically and biologically. Mol. Cell Biol. 2 1092–1100Google Scholar
  25. Thurow HS, Haack R, Hartiwig FP, Oliveira IO, Dellagostin OA, Gigante DP, Horta BL, Collares T and Seixas FK 2011 TP53 gene polymorphism: Importance to câncer, ethnicity and birth weight in a Brazilian cohort. J. Biosci. 36 823–831PubMedCrossRefGoogle Scholar
  26. Tommiska J, Eerola H, Heinonen M, Salonen L, Kaare M, Tallila J, Ristimäki K, von Smitten K, et al. 2005 Breast cancer patients with p53Pro72 homozygous genotype have a poorer survival. Clin. Cancer Res. 11 5098–5103PubMedCrossRefGoogle Scholar
  27. Whibley C, Pharoah PD and Hollsten M 2009 p53 polymorphisms:cancer implications. Nat. Rev. 9 95–107CrossRefGoogle Scholar
  28. Zhuo W, Zhang Y, Xiang Z, Cai L and Chen Z 2009 Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls. J. Exp. Clin. Cancer Res. 28 115PubMedCrossRefGoogle Scholar

Copyright information

© Indian Academy of Sciences 2012

Authors and Affiliations

  1. 1.Department of Biochemistry and Molecular Biology, Biological Sciences InstituteUniversidade Federal de GoiásGoiânia-GOBrazil

Personalised recommendations